@article{ref1,
title="Ketamine in bipolar disorder: A review",
journal="Neuropsychiatric disease and treatment",
year="2020",
author="Wilkowska, A. and Szałach, Ł. and Cubała, W.J.",
volume="16",
number="",
pages="2707-2717",
abstract="Bipolar disorder (BD) is a psychiatric illness associated with high morbidity, mortality and suicide rate. It has neuroprogressive course and a high rate of treatment resistance. Hence, there is an unquestionable need for new BD treatment strategies. Ketamine appears to have rapid antidepressive and antisuicidal effects. Since most of the available studies concern unipolar depression, here we present a novel insight arguing that ketamine might be a promising treatment for bipolar disorder. © 2020 Wilkowska et al.<p /><p>Language: en</p>",
language="en",
issn="1176-6328",
doi="10.2147/NDT.S282208",
url="http://dx.doi.org/10.2147/NDT.S282208"
}